KLRB1 and chronic hepatitis: Previous studies reported the enrichment of CD161+CD4+ T cells in the liver during chronic hepatitis (48), and IFN-γ could facilitate liver fibrogenesis by CD161+CD4+ T cells through the IL-23/IL-17 axis in chronic hepatitis B virus infection (49).